MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1200/jco.2016.67.6999

Медицинская библиотека · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2016

Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States.

Yanik Elizabeth L, Achenbach Chad J, Gopal Satish, Coghill Anna E, Cole Stephen R, Eron Joseph J, Moore Richard D, Mathews W Christopher, Drozd Daniel R, Hamdan Ayad, Ballestas Mary E, Engels Eric A

СтатьяПоддержка NIH: внешняя программаResearch Support, N.I.H., IntramuralПеревод в очереди

Аннотация

PURPOSE: The biology of HIV-associated cancers may differ depending on immunologic and virologic context during development. Therefore, an understanding of the burden of Kaposi's sarcoma (KS) and non-Hodgkin lymphoma (NHL) relative to antiretroviral therapy (ART), virologic suppression, and CD4 count is important.

PATIENTS AND

METHODS

KS and NHL diagnoses during 1996 to 2011 were identified among patients with HIV infection in eight clinical cohorts in the United States. Among patients in routine HIV clinical care, the proportion of cases in categories of ART use, HIV RNA, and CD4 count at diagnosis were described across calendar time. Person-time and incidence rates were calculated for each category.

RESULTS

We identified 466 patients with KS and 258 with NHL. In recent years, KS was more frequently diagnosed after ART initiation (55% in 1996 to 2001 v 76% in 2007 to 2011; P-trend = .02). The proportion of patients with NHL who received ART was higher but stable over time (83% overall; P-trend = .81). An increasing proportion of KS and NHL occurred at higher CD4 counts (P < .05 for KS and NHL) and with undetectable HIV RNA (P < .05 for KS and NHL). In recent years, more person-time was contributed by patients who received ART, had high CD4 counts and had undetectable HIV RNA, whereas incidence rates in these same categories remained stable or declined.

CONCLUSION

Over time, KS and NHL occurred at higher CD4 counts and lower HIV RNA values, and KS occurred more frequently after ART initiation. These changes were driven by an increasing proportion of patients with HIV who received effective ART, had higher CD4 counts, and had suppressed HIV RNA and not by increases in cancer risk within these subgroups. An improved understanding of HIV-associated cancer pathogenesis and outcomes in the context of successful ART is therefore important.

Для цитирования: Yanik Elizabeth L, Achenbach Chad J, Gopal Satish, Coghill Anna E, Cole Stephen R, Eron Joseph J, Moore Richard D, Mathews W Christopher, Drozd Daniel R, Hamdan Ayad, Ballestas Mary E, Engels Eric A. Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016. DOI: 10.1200/jco.2016.67.6999.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.